Neurologist visit frequency was modestly higher among cancer cases than controls but declined over time in both settings, ...

A study suggests vitamin D may reduce long COVID symptoms at 8 weeks, although larger trials are needed to confirm benefits ...

Global pediatric HIV data show dolutegravir links to early modest weight gain that plateaus by year 2, easing concerns and ...

Steven Kheloussi, PharmD, explores how smarter clinical tools, multidisciplinary teams, and better care coordination can ...

Capping Medicare beneficiaries’ monthly insulin out-of-pocket costs at $35 was associated with steep reductions in spending ...

ATTAIN demonstrated placebo-adjusted weight reductions of roughly 9–11 percentage points at 72 weeks, with 27.3 lb (12.4%) ...

The FDA proposes MRD negativity as an accelerated approval end point to speed access to novel myeloma therapies.

Chronic stress activates the HPA axis, increasing cortisol and neuropeptides that impair gut barrier integrity, shift ...

Federal pharmacy benefit manager transparency reforms must contend with concentrated pharmaceutical markets that lack ...

A global cohort has tracked pediatric HIV growth after dolutegravir, showing early catch-up weight gain, then stable BMI ...

Collapsing the very-low-risk category reflects broader acceptance of active surveillance for Gleason 6 disease, while PARP ...

At the American Academy of Dermatology (AAD) 2026 Annual Meeting, experts emphasized the value of in-person networking, ...